Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Cynapsus Thera Cm Sh (CYNA)

Cynapsus Thera Cm Sh (CYNA)
40.48 +0.01 (+0.02%) 10/20/16 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Thu, Oct 20th, 2016
Day Low
40.47
Day High
40.49
Open 40.48
Previous Close 40.47 40.47
Volume 388,800 388,800
Avg Vol 139,670 139,670
Stochastic %K 58.16% 58.16%
Weighted Alpha +77.10 +77.10
5-Day Change +0.03 (+0.07%) +0.03 (+0.07%)
52-Week Range 10.54 - 40.67 10.54 - 40.67
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 532,220
  • Shares Outstanding, K 13,150
  • Annual Sales, $ 0 K
  • Annual Income, $ -21,530 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.49
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 8.70
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.26
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/10/16
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/16
See More
  • Average Estimate -0.75
  • Number of Estimates 4
  • High Estimate -0.68
  • Low Estimate -0.85
  • Prior Year 0.18
  • Growth Rate Est. (year over year) -516.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
39.42 +2.69%
on 09/23/16
Period Open: 40.20
40.67 -0.47%
on 10/10/16
+0.28 (+0.70%)
since 09/20/16
3-Month
15.83 +155.72%
on 07/21/16
Period Open: 15.86
40.67 -0.47%
on 10/10/16
+24.62 (+155.23%)
since 07/20/16
52-Week
10.54 +284.06%
on 03/23/16
Period Open: 14.32
40.67 -0.47%
on 10/10/16
+26.16 (+182.68%)
since 10/20/15

Business Summary

Cynapsus Therapeutics, Inc. is a specialty pharmaceutical company engaged in developing a drug used to treat the symptoms of Parkinson's disease. The Company's drug candidate, APL-130277, is a reformulation of apomorphine, which is approved in an injection formulation to rescue patients from `off` episodes....

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 40.50
1st Resistance Point 40.49
Last Price 40.48
1st Support Level 40.47
2nd Support Level 40.46
3rd Support Level N/A

See More

52-Week High 40.67
Last Price 40.48
Fibonacci 61.8% 29.16
Fibonacci 50% 25.60
Fibonacci 38.2% 22.05
52-Week Low 10.54

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Mastering Fibonacci: The Hidden Order in Market Movements